A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer

Clinical trial NCT01771458 · COMPLETED

Trial details

NCT number: NCT01771458
Sponsor: Institut Curie
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Reccurent/Metastatic Solid Tumor Disease

Start date: 2012-10-01
Primary completion: 2016-10-01
Enrollment: 742

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.